Skip to content
Mesothelioma.net
phone iconCall1-800-692-8608 chat icon Chat 24/7 Live Chat
Menu
  • Malignant Mesothelioma
    • About Mesothelioma
      • How to Survive Mesothelioma
      • 100 Questions & Answers about Mesothelioma (Free Book)
      • Symptoms
      • Diagnosis
      • Prognosis
      • Life Expectancy
    • Types
      • Pleural
      • Peritoneal
      • Epithelioid
      • Sarcomatoid
      • Biphasic
    • Stages
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
    • Additional Information
      • Causes
      • Asbestos and Its Dangers
      • Facts
      • Support
      • Financial Compensation
      • FREE Mesothelioma Packet
  • Treatment
    • Treatment Options
      • Surgery
      • Chemotherapy
      • Radiation Therapy
      • Multimodal Therapy
      • Medications
      • Palliative Treatment
    • Find Top Doctors
      • Doctors
      • Treatment Centers
      • Treatment & Doctors Near You
      • New Treatments
      • Care Providers
      • Clinical Trials
      • Costs
  • Asbestos Trusts
  • Compensation
  • Veteran Assistance
    • Mesothelioma and Veterans
      • VA Claims for Mesothelioma
      • Vietnam Veterans
    • Military Branches and Asbestos
      • Navy Veterans
      • Navy Ships
      • Marine Corps Veterans
      • Army Veterans
      • Air Force Veterans
      • U.S. Coast Guard
  • Surviving Mesothelioma
  • About Us / Contact
  • Home
  • ›
  • Malignant Mesothelioma
  • ›
  • Treatment
  • ›
  • Medications
  • ›
  • Paraplatin (carboplatin)
Page Updated: June 30, 2022

Paraplatin (carboplatin)

Kyle J. Becker Page Medically Reviewed and Edited by Kyle J. Becker, PharmD, MBA, BCOP

FREE Mesothelioma Packet

Fact Checked

This page has been fact checked by a Doctor of Pharmacy who specializes in Oncology. Sources of information are listed at the bottom of the article.

FREE Mesothelioma Packet

We make every attempt to keep our information accurate and up-to-date.

Please Contact Us with any questions or comments.

Paraplatin (carboplatin), a chemotherapy drug, treats several cancers through intravenous administration every one to three weeks. Carboplatin typically causes less severe side effects than cisplatin. It is an important chemotherapy drug for mesothelioma patients and is often used in combination with other drugs.

FREE Mesothelioma Packet

What Is Carboplatin?

Drugmakers developed and patented carboplatin in the 1970s. The U.S. Food and Drug Administration (FDA) did not approve this platinum-based chemotherapy drug until 1986, nearly a decade after the similar drug, cisplatin, came market.

Carboplatin was derived from cisplatin, its parent drug; therefore, the two drugs have similar properties and uses. Paraplatin is made by Bristol-Myers Squibb, while generic carboplatin could be made by Hospira, Teva Pharmaceuticals, and other companies.

Like cisplatin, carboplatin works by targeting and interfering with how rapidly-growing cells divide and thrive.[1]

Unfortunately, this drug does not differentiate between cancer cells and other healthy cells that grow and divide quickly. The lack of specificity and the presence of platinum cause several potential side effects. Carboplatin is used for a multitude of cancer types, including ovarian, mesothelioma, and lung cancer.

Carboplatin is administered through intravenous infusion. The procedure takes about fifteen minutes to an hour for each dose, and an infusion is administered every four weeks. A doctor or nurse administers carboplatin in a medical facility.[1]

Carboplatin for Mesothelioma

Although the FDA has not approved carboplatin for mesothelioma treatment. Still, it is a popular choice because the National Comprehensive Cancer Network (NCCN) recommends it, especially when used with other chemotherapy drugs.

Patients may easily develop a resistance to carboplatin when it is used alone. Combining carboplatin with other drugs can reduce resistance, often improving the response to treatment.

A common drug combination for pleural mesothelioma is carboplatin with pemetrexed, also known as Alimta.[2] Cisplatin has also been shown to be effective with pemetrexed. Some studies have shown that both combinations result in similar outcomes.

Doctors choose the specific combinations based on how the patient tolerates each drug and any preexisting conditions such as kidney damage.

Recent trials tested carboplatin with Alimta in elderly patients with mesothelioma. The results showed that elderly patients tolerated the combination nearly as well as a younger group of participants. The older patients also had similar disease outcomes and survival times.[3]

Additional studies tested the combination of carboplatin and pemetrexed with a third drug, bevacizumab. Bevacizumab is an anti-angiogenesis agent that works differently from chemotherapy by slowing the growth of new blood vessels to the tumor.

The trial was non-randomized and therefore had limitations; however, the strength of other trials using bevacizumab with cisplatin and pemetrexed have led the NCCN to recommend using this third agent when patients are no longer eligible for surgery.[4]

Common Side Effects of Carboplatin

Carboplatin is often preferred over cisplatin because some patients tolerate it better. Side effects are not only uncomfortable for the patient but may also limit medication dosage. Administering the full dose of chemotherapy is important to help treat the cancer as effectively as possible.

Carboplatin causes common side effects, including:[1]

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Mouth sores
  • Pain and tingling in hands and feet
  • Skin irritation at the injection site
  • Pain
  • Weakness
  • Hair loss
  • Change in the taste of food

An additional advantage of carboplatin over cisplatin is that it does not often cause toxicity in the kidneys, a serious potential complication of cisplatin.

Carboplatin Black Box Warnings

The FDA uses a special warning label on medications for the most severe and life-threatening side effects and complications. Carboplatin comes with a few black box warnings. Both patients and doctors should weigh the risks and consequences of the potential benefits of this drug:

  • One serious warning for carboplatin is that it can suppress the bone marrow. The risk of this side effect increases with dosage. The bone marrow produces new blood cells, so suppression can lead to anemia, bleeding, and infections. These side effects can be severe enough to require blood transfusions.[1]
  • Another black box warning is aimed at patients with severe allergies to carboplatin injections. These patients may suffer anaphylactic shock, which can be fatal without immediate treatment. Signs of a severe reaction include hives and irritation at the injection site, swelling in the face, mouth, and throat, and difficulty breathing. These severe reactions may not be discovered until after the first dose. For this reason, carboplatin is only administered by healthcare professionals in an infusion center.

The Latest Carboplatin Research

Although it has been on the market for decades, mesothelioma researchers continue to investigate the effectiveness of therapies including carboplatin:

  • In 2014, researchers compared the use of carboplatin with mitomycin in treating peritoneal mesothelioma patients with HIPEC. They found carboplatin gave better results, including shorter hospital stays and longer survival times.[5]
  • Researchers reported in 2021 on the results of a comparison between carboplatin and cisplatin in pleural mesothelioma patients. This large study showed that carboplatin results in a comparable survival time.[6]
  • Two clinical trials involving carboplatin as part of therapy are recruiding mesothelioma patients. One is to investigate the use of radiation with standard chemotherapy and the other is testing chemotherapy with immunotherapy drugs.[7][8]

Carboplatin is a drug that was developed from cisplatin. Although these drugs are similar, there are significant differences. Some patients tolerate carboplatin better, but it still comes with serious risks. The worst risk is the drastic reduction in blood cells, resulting in anemia and a weakened immune system.

Patients with mesothelioma may be given carboplatin if they cannot tolerate cisplatin. It will provide good results for many of these patients, especially when taken in combination with other drugs.

Get Your FREE Mesothelioma Packet

Page Medically Reviewed and Edited by Kyle J. Becker, PharmD, MBA, BCOP

Kyle J. Becker

Kyle J. Becker, PharmD is certified by the Board of Pharmacy Specialties in Oncology Pharmacy. Dr. Becker earned his pharmacy degree from Shenandoah University and he currently serves as an oncology pharmacist at Parkview Cancer Institute.

Connect with Oncology Pharmacist Kyle J. Becker
References
  1. MedlinePlus. (2012, December 25). Carboplatin Injection.
    Retrieved from: https://medlineplus.gov/druginfo/meds/a695017.html
  2. American Cancer Society. (2018, November 16). Chemotherapy for Malignant Mesothelioma.
    Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/treating/chemotherapy.html
  3. Ceresoli, G.L., Castagneto, B., Zucali, P.A., Favaretto, A., Mencoboni, M., Grossi, F., Cortinovis, D., Del Conte, G., Ceribelli, A., Bearz, A., Salamina, S. De Vincenzo, F., Cappuzzo, F., Marangolo, M., Torri, V., and Santoro, A. (2008, June 10). Pemetrexed Plus Carboplatin in Elderly Patients wtih Malignant Pleural Mesothelioma: Combined Analysis of Two Phase II Trials. Brit. J. Cancer. 99, 51-6.
    Retrieved from: https://www.nature.com/articles/6604442
  4. Ceresoli, G.L., Zucali, P.A., Mencoboni, M., Botta, M., Grossi, F., Cortinovis, D., Zilembo, N., Ripa, C., Tiseo, A.G., Favaretto, H., Soto-Parra, H., De Vincenzo, F., Bruzzone, A., Lorenzi, E., Gianoncelli, L., Ercoli, B., Giordano, L, and Santoro, A. (2013, August 6). Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab as First-Line Therapy in Malignant Pleural Mesothelioma. Br. J. Cancer. 109(3), 552-8.
    Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/23860535
  5. Shetty, S.J., Bathla, L., Govindarajan, V., Thomas, P., and Loggie, B.W. (2014, April). Comparison of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Mitomycin or Carboplatin for Diffuse Malignant Peritoneal Mesothelioma. Am. Surg. 80(4), 348-52.
    Retrieved from: https://pubmed.ncbi.nlm.nih.gov/24887664/
  6. Nyberg, K. (2021, January 27). Real-World Data Show That Survival Just as Good With Carboplatin Therapy as With Cisplatin Therapy in Malignant Pleural Mesothelioma. IASLC.
    Retrieved from: https://www.iaslc.org/iaslc-news/ilcn/real-world-data-show-survival-just-good-carboplatin-therapy-cisplatin-therapy
  7. Memorial Sloan Kettering Cancer Center. (2022, January 28). A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma.
    Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04162015
  8. NRG Oncology. (2021, November 8). Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma.
    Retrieved from: https://clinicaltrials.gov/ct2/show/NCT04158141
View All References

Site Navigation

Home
Malignant Mesothelioma
How to Survive Mesothelioma
100 Questions & Answers about Mesothelioma (Free Book)
Surviving Mesothelioma - Beating the Odds (Free Book)
FREE Mesothelioma Packet
Symptoms
Shortness of Breath
Cough
Night Sweats and Fever
Weight Loss
Pain
Difficulty Swallowing
Fatigue and Muscle Weakness
Gastrointestinal Complications
Diagnosis
Pathology
Staging
Stage 1
Stage 2
Stage 3
Stage 4
Metastasis and Progression
Brain Metastasis
Biopsy
miRview Test
Imaging
Fine Needle Aspiration Biopsy in Mesothelioma
Biomarkers and Blood Tests
Calretinin
Prognosis
Remission
Recurrence
Death Rate
Life Expectancy
Search for a Mesothelioma Cure
Types
Pleural
Peritoneal
Epithelioid
Sarcomatoid
Biphasic
Pericardial
Testicular
Cell Types
Rare Subtypes of Mesothelioma
Deciduoid
Desmoplastic
Heterologous
Lymphohistiocytoid
Well-Differentiated Papillary
Tubulopapillary
Small Cell
Benign
Adenomatoid
Cystic
Unresectable
Localized
Idiopathic
Omental
Causes
Risk Factors
Latest Research
Genetic Components
Incidence
Latency Period
Mesothelioma Tumor
Health Insurance Coverage
Related Conditions
Immunodeficiency Disorders
Cholangiocarcinoma
Atelectasis
Pleural Plaques
Pleural Thickening
Pleural Effusion
Peritoneal Effusion (Ascites)
Mesothelial Hyperplasia and Proliferation
Pleuritis and Pleurisy
COPD
Anemia
Breast Cancer
Prevention
Complications
Misdiagnosis
Mesothelioma Commercial
Talcum Baby Powder
Lawyer
Lawsuits
Class Action Lawsuits
Settlements
Simian Virus 40
Differences From Other Cancers
Lung Cancer
Women
Children and Young Adults
Unknown Asbestos Exposure
Mesothelioma Without Asbestos
Cause of Death
Facts 
History
Awareness
Government and Research
National Mesothelioma Virtual Bank
Support
What to Expect
Living with Mesothelioma
Help a Loved One
Wrong and Right Things to Say
Caregivers
Financial Tips
Faith
Nutrition and Lifestyle
Intimacy
Mesothelioma and Fertility in Men
Fertility in Women with Mesothelioma
Emotional Health
COVID-19
Assisted Living
Hospice Care
Dying from Mesothelioma
Mourning
Coping Guide for Children
End-of-Life Decisions
Mesothelioma Awareness Day
Compensation for Victims
Lawyer
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington D.C.
Washington
West Virginia
Wisconsin
Wyoming
Lawsuit
Settlements
Statute of Limitations
Treatment
Surgery
Side Effects
Pneumonectomy
Extrapleural Pneumonectomy
Lobectomy
Pleurectomy/Decortication
Post Op Care
Pleurectomy/Decortication vs. Extrapleural Pneumonectomy
Peritonectomy/Cytoreductive Surgery
Thoracotomy
Thoracoscopy
Pericardiectomy
Wedge Resection
Pleurodesis
Pericardiocentesis
Prosthetics
Paracentesis
Thoracentesis
Chemotherapy
Side Effects
Heated Intraperitoneal
Radiation Therapy
Side Effects
Intensity-Modulated
Brachytherapy
Proton Therapy
Image-Guided
External Beam
Three-Dimensional
Multimodal Therapy
New Treatments
SMART Protocol
Gene Therapy
Suicide Gene Therapy
Tumor-Based p53 Therapy
Cryotherapy for Mesothelioma
Tumor Treating Fields
MicroRNA
Palliative Treatment
Osteopathic
Doctors
Treatment Centers
Treatment & Doctors Near You
Mesothelioma Experts
Medications
Alimta (pemetrexed)
Adriamycin (doxorubicin)
Avastin (bevacizumab)
Cytoxan (cyclophosphamide)
Gemzar (gemcitabine)
Keytruda (Pembrolizumab)
Mitomycin
Navelbine (vinorelbine)
Opdivo (nivolumab) and Yervoy (ipilimumab)
Paraplatin (carboplatin)
Platinol (cisplatin)
Rheumatrex (methotrexate)
Sutent (sunitinib)
Taxol (paclitaxel)
Medical Marijuana
Care Providers
Clinical Trials
Anetumab Ravtansine
Atezolizumab
Chimeric Antigen Receptor (CAR) T-Cell
Durvalumab
Immunotoxin
Interferon Alfa-2b
Onconase (Ranpirnase)
VISTA Protein
Costs
Immunotherapy
Nanotechnology
Hyperbaric Oxygen Therapy
Home Medical Equipment
HMGB1 Secretion
Photodynamic Therapy
Targeted Therapies
Apoptosis
Stem Cells
Lung Transplantation
Body-Based Therapies
Alternative Therapies
Paul Kraus’s Method
Doctors and Treatment in Canada
Asbestos Trusts
Veterans
VA Claims for Mesothelioma
Vietnam Veterans
Military Branches and Asbestos
Navy Veterans
Navy Ships
Aircraft Carriers
Battleships
Destroyers
Asbestos on Navy Cruisers
Submarines
Amphibious Ships
Minesweepers
Auxiliary Ships
Marine Corps Veterans
Army Veterans
Air Force Veterans
U.S. Coast Guard
Asbestos
Occupational Exposure
Construction Workers
Shipyard Workers
Ship Repair
Steel Mill Workers
Industrial Workers
Boiler Workers
Power Plant Workers
Firefighters
Automotive Workers
Roofers
Oil Refineries
Mining
Transportation Industry
Machine Operators
Farmers and Agricultural Workers
Migrant Workers
Electrical Wiring
Labor Unions
Prisons
Chimneys, Furnaces, and Wood Stoves
Fiberglass Connection to Mesothelioma
Home Remodeling
School Buildings, Teachers
For Tech Students
Cancer
Lung Cancer
Pleural Based Cancers
Ovarian Cancer
Ovarian Cancer Lawsuits
Companies That Used Asbestos
Awareness and Education
Types of Asbestos & Mesothelioma Risk
Asbestosis
Interstitial Lung Disease
Smoking
Asbestos Ingestion
Exposure in a Natural Disaster
Ban Asbestos
Libby, Montana
Recycling Asbestos
Asbestos Detection
Legal Information by State
Canada
Mexico
United Kingdom
Australia
  • Malignant Mesothelioma
    • Treatment
    • Asbestos Trusts
  • Compensation
    • Veteran Assistance
    • Surviving Mesothelioma
  • FREE Mesothelioma Packet
    • Mesothelioma News
    • About Us / Contact
  • Privacy Policy
    • Disclaimer
    • Editorial Guidelines and Standards
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.
The information provided by Mesothelioma.net is not a substitute for professional medical advice, diagnosis or treatment.

Mesothelioma.net

5430 LBJ Freeway Suite 1200
Dallas, Texas 75240

Serving mesothelioma victims nationwide

1-800-692-8608

  • facebook
  • twitter
© 2022 Mesothelioma.net